Hiroki Ureshino Selected Research

Hiroki Ureshino Research Topics

6	Neoplasms (Cancer) 01/2021 - 05/2010
3	Pancreatic Neoplasms (Pancreatic Cancer) 10/2016 - 01/2010
2	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 01/2020
2	Stomach Neoplasms (Stomach Cancer) 05/2013 - 05/2011
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 12/2020
1	Leiomyoma (Uterine Fibroids) 12/2020
1	Adenocarcinoma 06/2020
1	Neoplasm Metastasis (Metastasis) 06/2020
1	Disease Progression 01/2020
1	Situs Inversus 01/2010
1	Ductal Carcinoma 01/2009

4	Proteins (Proteins, Gene)FDA Link 10/2016 - 05/2010
2	ErbB Receptors (EGF Receptor)IBA 10/2016 - 05/2013
2	CXC ChemokinesIBA 08/2013 - 05/2010
1	Prothrombin (Factor II)IBA 01/2021
1	Collagen Type IV (Type IV Collagen)IBA 12/2020
1	DesminIBA 12/2020
1	RamucirumabIBA 01/2020
1	Fluorine-18IBA 10/2016
1	Glucose (Dextrose)FDA LinkGeneric 10/2016
1	TOR Serine-Threonine KinasesIBA 10/2016
1	Monoclonal AntibodiesIBA 10/2016
1	Ribosomal Protein S6IBA 10/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2013
1	matrigelIBA 08/2013
1	CytokinesIBA 08/2013
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 08/2013
1	Matrix Metalloproteinases (MMPs)IBA 08/2013
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 08/2013
1	Lapatinib (GW572016)FDA Link 05/2013
1	Trastuzumab (Herceptin)FDA Link 05/2013
1	Biomarkers (Surrogate Marker)IBA 05/2011
1	NF-kappa B (NF-kB)IBA 05/2010
1	NF-KappaB Inhibitor alphaIBA 05/2010
1	Serine (L-Serine)FDA Link 05/2010
1	Phosphotransferases (Kinase)IBA 05/2010
1	Threonine (L-Threonine)FDA Link 05/2010

3	Pancreaticoduodenectomy 12/2020 - 01/2010
2	Pancreatectomy 01/2010 - 01/2009
1	Hepatectomy 01/2021
1	Drug Therapy (Chemotherapy) 06/2020
1	Therapeutics 05/2013
1	Lymph Node Excision (Lymph Node Dissection) 01/2010
1	Splenectomy 01/2009